i-Health introduces Culturelle Baby
To help support the growth of good bacteria in a baby’s tummy, Cromwell, Conn.-based i-Health recently introduced Culturelle Baby, a line of probiotic products specifically formulated for babies 0–24 months.
“New parents have enough to think about when it comes to creating a healthy foundation for their newborn. Culturelle Baby gives them the peace of mind that comes with a clinically studied probiotic strain, in an easy-to-use format,” Nicole Bourdeau, senior brand manager for Culturelle Kids and Baby, said. “That way, parents can spend more time enjoying their baby’s other milestones in those first few years.”
“A healthy microbiome can have a positive effect on baby’s digestive and immune functioning,” Jen Trachtenberg, a pediatrician and Culturelle spokesperson, said. “Restoring the balance of good bacteria can be beneficial in the short term by reducing digestive issues that may be causing baby’s fussiness, while also helping to build up their natural immune defenses to promote long-term health.”
Culturelle Baby products contain Lactobacillus rhamnosus GG, the most clinically studied probiotic strain in infants and are free of GMOs, gluten, dairy and dyes.
Culturelle Baby Calm + Comfort probiotic drops with chamomile help reduce crying and fussiness due to occasional digestive upset, by restoring the balance of healthy bacteria in a baby’s digestive system. Culturelle Baby Grow + Thrive contains both LGG and Bifidobacterium lactis BB-12 probiotic strains to help support the healthy development of a baby’s digestive and immune systems. It supplements the good bacteria naturally found in breast milk and contains vitamin D for strong bones.
Culturelle Baby is available now at Amazon.com, and will be introduced in-store at major retailers beginning this month with a suggested retail price of $25.99.
Randob Labs acquires heritage skin protectant brand Balmex
Privately-held Randob Labs on Thursday acquired the Balmex brand of skin protectants from Moberg Pharma as part of a $4.3 million deal.
“We are excited to add the Balmex brand to our OTC lineup at Randob, which already includes the core and expanding Dormin sleep aid and Sting-Kill anti-itch brands,” Jim Creagan, president of the Cornwall, N.Y.-based supplier, said. “Balmex, which will celebrate 65 years in 2018, has had a loyal following for generations of mothers because it provides the gentle, yet effective care that all mothers want for their babies.”
Randob Labs has built a reputation around taking heritage brands and making them relevant to today’s marketplace. “We plan to increase the Balmex brand’s relevance, distribution and sales by tapping into the channels and conversations that moms and those who influence them are having online, similar to the strategies we are using to grow our Dormin and Sting-Kill brands,” Creagan said. “In addition to baby care, there are also expansion opportunities in the adult market as boomers age and have specific skincare needs.”
Creagan noted that the 3.3% growth in the diaper rash category is twice that of overall OTC market growth (1.8%). In addition to the approxiate 4 million births every year, more than 15% of the U.S. population is over the age of 70.
The transaction, expected to close in April, includes four baby care SKUs and two adult care SKUs. The brand was originally acquired from Chattem (now Sanofi Consumer Healthcare) in April 2015, Moberg Pharma reported.
higi ties health kiosk readings to EHRs through Rush partnership
Higi, a Chicago company that operates a national network of more than 11,000 health self-screening stations for population health enablement, on Thursday announced the development of a new app that will allow higi users to have data from their screening shared with health care providers who maintain electronic health records (EHRs) in Epic, the most widely-used system. The Rush University Medical Center in Chicago built the app in conjunction with higi.
“Higi is proud to partner with Rush on this important integration, which enables Rush and other organizations who use the Epic EHRs to connect with our more than 11,000 publicly-accessible higi stations to extend their reach into communities, enable more convenient measurement of health data, gain insight into social determinants of health and inform patient treatment plans,” Jeff Bennett, CEO higi, said.
“At Rush, we are focused on improving the health of our surrounding communities,” Shafiq Rab, senior vice president and chief information officer at Rush, said. “A leading cause of morbidity and mortality in Chicago’s West Side is unmanaged hypertension and heart disease. By connecting higi health stations with Epic workflows, we are trying to improve access to care, regularly measure biometrics and work with our community partners to better understand and address social determinants of health.”
In the initial launch of the higi-Epic EHR integration, planned to begin during the third quarter of 2018, Rush patients who receive specialized care for hypertension will be able to measure their biometrics at 211 Jewel-Osco, Meijer, Sams Club and select CVS pharmacy locations across the Chicago area. With the patients’ consent, data from higi will be shared immediately and securely with trusted Rush care providers in Epic’s hypertension registries to decrease the need for blood pressure check visits to Rush clinics.
Based on the results of the launch, this program will be extended to 60,000 additional Rush patients with chronic conditions such as hypertension, pre-diabetes and diabetes.
Also as part of this initiative, Rush is placing additional higi stations into community centers, high schools and other locations to improve access and to address social needs that affect overall health and well-being. Rush’s first higi station deployment was to Franciscan House of Mary and Joseph, a not-for-profit homeless shelter near Rush on Chicago’s West Side where Rush clinicians and students provide free medical services.
At Franciscan House, the Rush team detected a prevalence of severe hypertension in residents that was multiple times higher than for people in the greater Chicago area. This finding inspired Rush’s information technology team to create an interoperable integration with Rush’s Epic EHRs to ensure that data from higi is accessible in real time for Rush clinicians or other community-based providers.
In addition, the higi team is working with the Rush IT team to make the higi – Epic EHR integration application available on the Epic App Orchard marketplace for adoption by other health systems and physician groups that use Epic EHR solutions.